Johnson & Johnson discontinues dengue drug study-February 2024-www.financetom.com

Johnson & Johnson discontinues dengue drug study

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Johnson & Johnson discontinues dengue drug study

Oct 4, 2024 8:18 AM

Oct 4 (Reuters) - Johnson & Johnson ( JNJ ) said on

Friday it will discontinue its mid-stage field study evaluating

the efficacy of its antiviral drug candidate for the prevention

of dengue.

Previous page： Update: Confluent Shares Fall After Reporting Q1 Financial Results Next page： Google agrees $36 million fine for anti-competitive deals with Australia telcos

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Update: Confluent Shares Fall After Reporting Q1 Financial Results

May 25, 2025

01:37 PM EDT, 05/01/2025 (MT Newswires) -- (Updates with the latest stock price movement in the headline and first paragraph.) Confluent's (CFLT) shares were down nearly 18% in recent Thursday trading, a day after the company reported Q1 non-GAAP net income of $0.08 per diluted share, up from $0.05 a year earlier. Analysts polled by FactSet expected $0.07. Revenue for...

Google agrees $36 million fine for anti-competitive deals with Australia telcos

Aug 17, 2025

SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...

Ouster Expands Partnership With LASE PeCO to Deploy Sensors and Software in Europe

May 25, 2025

01:37 PM EDT, 05/01/2025 (MT Newswires) -- Ouster (OUST) said Thursday it entered an agreement with LASE PeCo to deploy 3D digital lidar technology in Europe. The multi-million dollar agreement builds on an existing partnership between the companies and will introduce additional sensors and Ouster Gemni perception software licenses to LASE PeCO's European clients, according to a statement. LASE PeCo...

MYR Group Shares Rise After Higher Q1 Earnings, Revenue

May 25, 2025

01:37 PM EDT, 05/01/2025 (MT Newswires) -- MYR Group ( MYRG ) shares jumped 17% in recent Thursday trading after the company reported higher Q1 earnings and revenue that topped expecations. The company reported Q1 earnings late Wednesday of $1.45 per diluted share, up from $1.12 a year earlier. Analysts polled by FactSet expected $1.20. Revenue for the quarter ended...